The expanded testing capabilities leverage long-read sequencing technology to detect disorders such as Fragile X syndrome, adult neurological conditions, certain ataxias, and more.
Read More
The expanded menu brings the number of tests to 67, with samples requiring only a pea-sized drop of blood collected from a fingertip.
Read More
Three-year PERIBLOOD study will evaluate single-cell RNA sequencing as minimally invasive alternative to bone marrow aspiration for blood disorder diagnosis.
Read More
Study shows Foresight CLARITY demonstrated 68% pre-operative and 38% post-operative MRD detection rates in stage I lung cancer patients.
Read More
A recent poll highlights growing interest in host response testing for sepsis. Immunexpress CEO Rollie Carlson discusses the findings and the future of rapid diagnostics.
Read More